306 cases · page 2 of 11
Showing 31–59Amgen Inc. v.Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Regeneron Pharmaceuticals Inc.
This is a decision of the Court of Appeal of the Unified Patent Court issued on 25 November 2025 concerning appeals in a revocation action and a counterclaim for revocation (case numbers UPC_CoA_528/2024 and UPC_CoA_529/2024). The judgment sets out headnotes addressing key legal principles on claim interpretation, added matter, sufficiency of disclosure, and inventive step. The decision establishes guidance on interpreting dependent claims, medical use-format claims, the assessment of added matter, the test for sufficiency including functional features, and the framework for evaluating inventive step.
Amgen Inc. v.Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Regeneron Pharmaceuticals Inc.
This is a decision of the Court of Appeal of the Unified Patent Court issued on 25 November 2025 concerning appeals in a revocation action and a counterclaim for revocation (case numbers UPC_CoA_528/2024 and UPC_CoA_529/2024). The decision sets out headnotes addressing key patent law principles including claim interpretation, added matter, sufficiency of disclosure, and inventive step. The judgment establishes legal guidelines on how dependent claims inform main claim interpretation, the inherent therapeutic effectiveness requirement in medical use-format claims, the legal nature of added matter assessment, and the standards for sufficiency and inventive step analysis.
TP-Link Systems Inc, TP-Link Deutschland GmbH, TP-Link Entreprises France SARL, TP-LINK Enterprises Netherlands B.V, TP-Link Italia S.R.L., TP-LINK Enterprises Nordic AB, Lianzhou International Co., Ltd., v.Huawei Technologies Co. Ltd.
This order concerns an application by the Defendants (TP-Link entities and Lianzhou International) to change the language of proceedings from German to English in an infringement action brought by Huawei Technologies Co. Ltd. concerning European patent EP 3678321. The Defendants argued that English, the language in which the patent was granted, should be used as the language of proceedings for reasons of fairness, citing the strict time constraints of the UPC rules of procedure, the internal working language of the parties, and the need for rapid coordination among the multiple Defendants. Huawei opposed the application and requested its dismissal. The matter was referred to the President of the Court of First Instance under Rule 323 RoP, with the panel of the Local Division Munich consulted.
Solvay Specialty Polymers Italy S.p.A. v.Zhejiang Fluorine Chemical New Material Co. a.o.
1. One of the circumstances relevant to admission to a confidentiality club is whether the individual is an employee of the party, an employee of the party’s economic unit or an employee of a third party. 2. If it is possible for a person who is not an employee of the party to join a confidentiality club, it is – depending on the relevant circumstances of the case – in any case justified for employees of the party or its economic unit to be admitted to a confidentiality club. UPC_CFI_7
Skechers USA Deutschland GmbH, Skechers S.a.r.l, Skechers U.S.A., Inc., Skechers EDC SPRL, Skechers USA Italia Srl, Skechers USA France SAS v.FAST IP, LLC
FAST IP LLC brought an infringement action against multiple Skechers group entities based on European patent EP4003084 concerning rapid-entry footwear. The Defendants applied under R. 323 RoP to change the language of the proceedings from German to English, the language in which the patent was granted. The Claimant opposed the application. The President of the Court of First Instance issued an order addressing the application to change the language of the proceedings.
BF exaQC AG v.NVIDIA Corporation a. o.
The Local Division Munich of the Unified Patent Court addressed the Defendants' application for security for costs in patent infringement proceedings concerning European Patent EP 3 614 263. The Defendants argued that Claimant ParTec AG faced severe liquidity problems based on press reports, while the Claimants contended they had sufficient assets to cover any adverse costs award. The judge rapporteur ordered Claimant ParTec AG to provide security in the amount of EUR 80,500.00 within six weeks, either by deposit or bank guarantee from an EU-licensed bank.
Shangrao Xinyuan Yuedong Technology Development Co., Ltd v.LONGi Solar Technologie GmbH a.o.
The Claimant filed a patent infringement action against five Defendants concerning European patent EP 3 297 043 B1. Following settlement negotiations, the Claimant and Defendants 1–4 reached a comprehensive settlement agreement, and Defendant 5 agreed to the withdrawal. The Court permitted the withdrawal, declared the proceedings closed, ordered each party to bear its own extrajudicial costs, and granted the Claimant a 60% reimbursement of court fees (€6,600).
ONWARD Medical N.V v.Niche Biomedical, Inc.
ONWARD Medical N.V. sought interim injunctive relief against Niche Biomedical, Inc. (doing business as ANEUVO) for alleged infringement of European Patent EP 3 421 081 B1, directed to a system for neuromodulation. The Local Chamber Munich of the Unified Patent Court addressed the legal principle that auxiliary requests seeking interim measures based on alternative claim formulations deviating from the granted patent version are generally inadmissible in provisional proceedings under Article 62 EPGÜ. The court held that a patent proprietor's request to amend the claim formulation indicates that the patent as granted is likely invalid, undermining the court's ability to assess the validity required for granting interim relief.
Edwards Lifesciences Corporation v.Meril GmbH a.o.
This case concerns an application for a cost decision by Edwards Lifesciences Corporation following a 4 April 2025 order requiring the three Meril defendants to jointly and severally bear the costs of the proceedings. Edwards sought reimbursement of EUR 774,696.49 in costs of representation, court fees, travel expenses, and other costs, while Meril contested the necessity and proportionality of various travel-related expenses. The Local Division Munich, through Judge-Rapporteur Dr. Matthias Zigann, held that UPC representatives have broad discretion in determining how to effectively represent their parties, and that the disputed travel costs were marginal relative to the overall costs, warranting award at the judge's discretion.
AX Wireless, LLC v.1) Xiaomi Inc. 2) Xiaomi Corporation 3) Xiaomi Technology Germany GmbH 4) Xiaomi Technology Netherlands B.V.
AX Wireless, LLC filed a patent infringement action against four Xiaomi entities before the Local Division Munich of the Unified Patent Court concerning European Patent No. EP3072324. The Defendants requested an extension and alignment of procedural deadlines for all four Defendants so that a consolidated defence could be filed, and the Claimant consented. The Court granted the request, aligning the deadlines for all Defendants.
Brita SE v.1) AQUASHIELD EUROPE s.r.o, 2. AQUASHIELD DACH GmbH, 3. Gasmarine BV Srl, 4. MGR26 Société à responsabilité limitée
1 Entscheidung des Gerichts erster Instanz des Einheitlichen Patentgerichts erlassen am 16.10.2025 KLÄGERIN UND NICHTIGKEITSWIDERBEKLAGTE Brita SE, gesetzlich vertreten durch den Vorstand Markus Hankammer, Stefan Rudolf Jonitz und Dr. Rüdiger Kraege, Heinz-Hankammer-Straße 1, 652
Motorola Mobility LLC v.1) ASUSTek Computer Inc 2) ASUS Computer GmbH 3) ASUSTEK (UK) LIMITED
Motorola Mobility LLC, the registered proprietor of European Patent EP 3 972 309, brought an infringement action against ASUSTek Computer Inc., ASUS Computer GmbH, and ASUSTEK (UK) Limited before the Local Chamber Munich. The patent concerns a method and apparatus for implementing carrier-specific changes as part of a connection reconfiguration affecting the security keys used in user equipment communicating with two cell groups. The defendants filed a counterclaim. The case was heard orally on July 9, 2025, and the decision was issued on October 10, 2025, by a panel of four judges.
Heraeus Electronics GmbH & Co. KG v.Vibrantz GmbH
This case concerns European Patent No. 3 215 288 B1, relating to metal sintering preparations, which is in force in Germany, France, Italy, and Romania. Heraeus Electronics GmbH & Co. KG filed an infringement action against Vibrantz GmbH, while Vibrantz filed a counterclaim for revocation along with applications for patent amendment and a decision on an absolute procedural bar. The Local Chamber Munich addressed the binding effect of a final national revocation judgment under Art. 24.1(e) of the Agreement on a Unified Patent Court, holding that in the absence of specific UPCA regulations, national law governs this question, and also examined private prior use rights in Germany, France, Italy, and Romania.
Guangdong OPPO Mobile Teleconmmunications Corp. Ltd. a.o. v.Crystal Clear Codec Sp.z.o.o.
ORDER of the President of the Court of First Instance in the proceedings before the Local Division MUNICH Issued on 18/09/2025 APPLICANTS (DEFENDANTS IN THE MAIN PROCEEDINGS): 1- Guangdong OPPO Mobile Telecommunications Corp. Ltd. No. 18 Haibin Road, Wusha, Chang’an Town, Guangdong Provinc
Sanofi-Aventis GmbH, Sanofi A/S, Sanofi Mature IP, Sanofi-Aventis France, Sanofi B.V., Sanofi - Produtos Farmaceuticos Lda, Sanofi Winthrop Industrie, Sanofi AB, Sanofi-Aventis Deutschland GmbH, Sanofi S.r.l., Sanofi Belgium v.Zentiva Pharma GmbH, Zentiva France, Zentiva, k.s.
This is a procedural order issued by the Local Division Munich of the Court of First Instance on 15 September 2025, following the second interim conference in four consolidated infringement actions concerning European patent EP 2 493 466. The claimants are multiple Sanofi entities, and the defendants are generic pharmaceutical companies from four groups: Accord Healthcare, STADA, Reddy Pharma, and Zentiva. The order addresses procedural matters including the status of the EPO Board of Appeal decision, expert testimony arrangements, the schedule for the oral hearing scheduled for 14–17 October 2025, and rulings on the admissibility of late-filed evidence.
Sanofi A/S, Sanofi-Aventis GmbH, Sanofi S.r.l., Sanofi B.V., Sanofi-Aventis Deutschland GmbH, Sanofi AB, Sanofi Winthrop Industrie, Sanofi - Produtos Farmaceuticos Lda, Sanofi Belgium, Sanofi Mature IP v.Accord Healthcare BV, Accord Healthcare, Unipessoal Lda., Accord Healthcare S.L.U., Accord Healthcare GmbH, Accord Healthcare Italia Srl, Accord Healthcare AB, Accord Healthcare B.V.
This is a procedural order issued by the Local Division Munich of the Court of First Instance on 15 September 2025, concerning four consolidated infringement actions and counterclaims related to European patent n° 2 493 466. The order, issued following the second interim conference, sets out the schedule and procedural arrangements for the oral hearing scheduled for 14–17 October 2025, addresses expert testimony, and rules on the admissibility of late-filed evidence. The patent was upheld by the EPO Board of Appeal at an oral hearing on 2–4 June 2025, with written reasons pending.
Sanofi S.r.l., Sanofi-Aventis Deutschland GmbH, Sanofi B.V., Sanofi Winthrop Industrie, Sanofi - Produtos Farmaceuticos Lda, Sanofi Belgium, Sanofi Mature IP, Sanofi AB, Sanofi-Aventis GmbH, Sanofi-Aventis France, Sanofi A/S v.STADA Nordic ApS, STADA Arzneimittel AG, STADAPHARM GmbH
This is a procedural order from the Local Division Munich of the Unified Patent Court concerning infringement actions related to European Patent No. 2 493 466. The Presiding Judge confirmed that expert testimony from two party experts would be heard at the oral hearing scheduled for 14-17 October 2025, addressing questions about the Phase III TROPIC study and reasonable expectation of success. The order summons the party experts and sets out the schedule, structure, and procedural framework for their testimony.
Sanofi A/S, Sanofi - Produtos Farmaceuticos Lda, Sanofi B.V., Sanofi Belgium, Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis France, Sanofi-Aventis GmbH, Sanofi S.r.l., Sanofi AB, Sanofi Mature IP v.Dr Reddy's Srl, betapharm Arzneimittel GmbH, Reddy Pharma SAS
Procedural order from the Local Division Munich concerning four consolidated infringement actions relating to European patent n° 2 493 466. The order, issued following the second interim conference, addresses the status of the EPO Board of Appeal decision, expert testimony arrangements, the schedule for the oral hearing scheduled for 14–17 October 2025, and various evidentiary rulings including the rejection of a late-filed affidavit by Zentiva.
ECOVACS Europe GmbH v.Respondent
This is a procedural order concerning a request for extension of deadlines filed by Defendant 2 (ECOVACS Europe GmbH) in a patent infringement action brought by Papst Licensing GmbH & Co. KG. The plaintiff alleges infringement of European Patent EP 3 494 446 against four Ecovacs group entities in China, Germany, France, and the United States. Defendant 2 seeks to extend the deadline for filing its statement of defense and any counterclaim for invalidity until November 26, 2025, and the deadline for filing a Preliminary Objection until September 26, 2025, offering in return to facilitate service on the other three defendants to create a uniform deadline regime.
Belparts Group N.V. v.Respondent
Belparts Group N.V. filed an application under Rule 302.3 of the Rules of Procedure seeking consolidation of its infringement action pending before the Local Division Munich with a counterclaim for infringement pending before the Central Division Paris, both based on European patent EP 3 812 870. Despite the defendants' consent, the Presiding Judge dismissed the application, holding that the statutory prerequisite of proceedings being before the same local, regional, or central division was not satisfied.
Xiaomi Technology Germany GmbH v.Respondent
This is a procedural order issued by the Local Division Munich in a patent infringement action concerning European Patent EP 2 385 739. The plaintiff, UERAN Technology LLC, has brought claims against seven Xiaomi group entities. Defendant 5, Xiaomi Technology Germany GmbH, requested the court to establish a unified deadline regime for all defendants and to extend the deadlines for reply and rejoinder by two weeks each to account for the Christmas and Easter holiday periods.
Shanghai Jinko Green Energy Enterprise Management Co., Ltd., Zhejiang Jinko Solar Co., Ltd. v.Respondent
This is a procedural order from the Local Division Munich concerning European Patent No. 4 372 829, in which the claimants (Jinko entities) and the defendants (LONGi entities and others) jointly requested a stay of both the infringement proceedings and the counterclaim for revocation. The court granted the stay because the parties were engaged in negotiations for a comprehensive settlement agreement, ordering the claimants to notify the court of the outcome within six months.
KNAPP Smart Solutions GmbH v.Respondent
This procedural order concerns a deadline extension request in a patent infringement and revocation dispute involving European Patent EP 2 133 289. Due to irregularities in the CMS, the filing dates of the defendant's reply and counterclaim for revocation were inconsistent, creating uncertainty about the applicable deadlines. The plaintiff requested a six-day extension to September 9, 2025, which the defendant agreed to, but the court only partially granted the request, extending the deadline to September 5, 2025, to avoid subsequent deadlines falling on a weekend.
MediaTek Germany GmbH v.Respondent
This is a procedural order from the Local Division Munich concerning an infringement action based on European Patent EP 3 905 840 B1. Defendant MediaTek Germany GmbH sought an order requiring the plaintiff Huawei Technologies Co. Ltd to provide security for costs under Article 69(4) EPGÜ and Rule 158.1 RoP, arguing that as a Chinese-domiciled entity, enforcement of a cost order in China would be uncertain. Huawei countered by providing a legally binding assurance that any cost decision could be served on its German subsidiary, Huawei Technologies Deutschland GmbH.
Taylor Wessing PartG mbB v.Respondent
Taylor Wessing PartG mbB, a law firm, applied under Rule 262.1(b) RoP for access to written pleadings and evidence in terminated proceedings between NEC Corporation and various TCL entities concerning European patent EP 2 645 714. NEC opposed the request, arguing it was not a reasoned request and that the stated educational purpose was pretexted. The Local Division Munich partially granted the request, allowing access to specific written pleadings in redacted versions, with personal data redacted and appendices to be provided upon further request.
Shangrao Xinyuan Yuedong Technology Development Co., Ltd v.Respondent
The Claimant filed an infringement action against five Defendants concerning European patent EP 3 297 043 B1 before the Local Division Munich. The Claimant and Defendants 1 to 4 jointly requested a stay of proceedings due to ongoing settlement negotiations, and the Claimant also sought a stay regarding Defendant 5. The Court granted the stay under Rules 295(d) and 295(m) RoP, extended the time limit for filing the Statement of defence to five months, and ordered the parties to inform the Court if a settlement is reached.
Network System Technologies LLC v.Qualcomm Technologies, Inc., Qualcomm Incorporated, Qualcomm Germany GmbH
The Local Division Munich of the Unified Patent Court rejected a preliminary objection by Qualcomm defendants challenging the court's jurisdiction over European Patent EP 1 552 669. The court held that the withdrawal of an opt-out from the court's exclusive competence was effective, even though the UPC representative who filed the withdrawal application was neither the patent proprietor nor a registered representative in the national patent registers. The court ruled that a UPC representative acting under Rule 5.3(b)(i) RoP is not required to submit a written mandate or power of attorney for the withdrawal to be effective.
Qualcomm Technologies, Inc., Qualcomm Germany GmbH, Qualcomm Incorporated v.Network System Technologies LLC
The Local Division Munich of the Unified Patent Court rejected a preliminary objection filed by the Qualcomm defendants in a patent infringement action concerning European Patent EP 1 552 399. The defendants argued that the court lacked jurisdiction because the patent had been validly opted out and the withdrawal of the opt-out was ineffective due to lack of proper authorization of the UPC representative who filed it. The court held that the withdrawal of the opt-out was effective, as a UPC representative acting under Rule 5.3(b)(i) RoP is not required to submit a written mandate or power of attorney for the withdrawal to be effective, and such lack of representation cannot be raised as a preliminary objection.
Qualcomm Germany GmbH, Qualcomm Technologies, Inc., Qualcomm Incorporated v.Network System Technologies LLC
The Local Division Munich of the Unified Patent Court rejected a preliminary objection filed by the Qualcomm defendants challenging the Court's jurisdiction over European Patent EP 1 875 683. The court held that the opt-out from the Court's exclusive competence had been effectively withdrawn on 20 December 2023 by a registered UPC representative, and that the lack of a written mandate or power of attorney could not be invoked as a preliminary objection under Rule 19.1(a) RoP.
Brita SE v.AQUASHIELD DACH GmbH, AQUASHIELD EUROPE s.r.o., Gasmarine BV Srl, MGR26 Société à responsabilité limitée
1 Entscheidung des Gerichts erster Instanz des einheitlichen Patentgerichts verkündet am 22. August 2025 betreffend EP 2 387 547 B1 LEITSÄTZE: 1. Zweckangaben in einem Vorrichtungsanspruch definieren eine Vorrichtung regelmäßig dahingehend, dass sie geeignet sein muss, für die
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.